按提供者类型划分的静脉消融手术,包括高级执业提供者
该研究分析2010至2018年医疗保险按服务付费数据,发现静脉消融手术量增长107%,高级执业提供者(APP)手术量年增62.0%,且APP和心脏科医生更倾向于使用非热消融技术。
要点
- 静脉消融手术总量从2010年114,197例增至2018年236,558例,增长107%(P < .001)。
- APP执行的消融手术年增长62.0%(95%CI 61.6%-62.4%),总手术年增长9.7%(95%CI 9.7%-9.8%)。
- APP使用非热消融的OR为2.60(95%CI 2.51-2.69),使用化学胶的OR为3.57(95%CI 3.43-3.70)。
核心结论
- 过去十年静脉手术使用迅速增加,尤其是血管内消融由更广泛的执业者(包括APP和非介入专科医生)实施。
- 不同提供者类型的实践模式存在差异,APP和心脏科医生更倾向于非热消融方式,包括更快速地采用新非热技术。
研究设计与样本
- 分析2010年至2018年医疗保险按服务付费数据,通过现行 procedural terminology 代码识别射频消融、血管内激光消融、化学粘合消融(即VenaSeal;Medtronic,Inc)和机械化学消融,并与执业者类型关联。
主要发现
- 2010年至2018年间,消融手术量从每年114,197例增至236,558例,增长107%(P < .001)。
- 大多数手术由无血管委员会认证的外科医生执行(28.7%;95%CI 28.7%-28.8%),其次是血管外科医生(27.1%;95%CI 27.0%-27.2%)。
- 传统非介入专科(排除外科医生、心脏科医生和介入放射科医生)占研究期间所有消融手术的14.1%(95%CI 14.1%-14.2%),APP占3.5%(95%CI 3.4%-3.5%)。
- 消融总数每年增长9.7%(95%CI 9.7%-9.8%),而APP执行的手术每年增长62.0%(95%CI 61.6%-62.4%)。
- APP对非热消融的亲和力最高(OR 2.60;95%CI 2.51-2.69),心脏科医生也更可能使用非热消融(OR 1.62;95%CI 1.59-1.66);APP(OR 3.57;95%CI 3.43-3.70)和心脏科医生(OR 1.86;95%CI 1.81-1.91)对新非热技术(即化学粘合剂)的采用率最高;血管外科医生较少使用非热方式(OR 0.95;95%CI 0.92-0.97),包括在新技术可用第一年使用新非热技术(OR 0.93;95%CI 0.90-0.95)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The necessary training and certification of providers performing venous ablation has become a topic of debate in recent years. As venous interventions have shifted away from the hospital, the diversity of provider backgrounds has increased. We aimed to characterize superficial venous ablation practice patterns associated with different provider types. METHODS: We analyzed Medicare Fee-For-Service data from 2010 through 2018. Procedures were identified by their Current Procedural Terminology code and included radiofrequency ablation, endovenous laser ablation, chemical adhesive ablation (ie, VenaSeal; Medtronic, Inc), and mechanochemical ablation. These procedures were correlated with the practitioner type to identify provider-specific trends. RESULTS: Between 2010 and 2018, the number of ablation procedures increased by 107% from 114,197 to 236,558 per year (P < .001). Most procedures were performed by surgeons without vascular board certification (28.7%; 95% confidence interval [CI], 28.7%-28.8%), followed by vascular surgeons (27.1%; 95% CI, 27.0%-27.2%). Traditionally noninterventional specialties, which exclude surgeons, cardiologists, and interventional radiologists, accounted for 14.1% (95% CI, 14.1%-14.2%), and APPs accounted for 3.5% (95% CI, 3.4%-3.5%) of all ablation procedures during the study period. The total number of ablations increased by 9.7% annually (95% CI, 9.7%-9.8%), whereas procedures performed by APPs increased by 62.0% annually (95% CI, 61.6%-62.4%). There were significant differences between specialties in the use of nonthermal ablation modalities: APPs had the highest affinity for nonthermal ablation (odds ratio [OR], 2.60; 95% CI, 2.51-2.69). Cardiologists were also more likely to use nonthermal ablation (OR, 1.62; 95% CI, 1.59-1.66). Similarly, the uptake of new nonthermal technology (ie, chemical adhesives) was greatest among APPs (OR, 3.57; 95% CI, 3.43-3.70) and cardiologists (OR, 1.86; 95% CI, 1.81-1.91). Vascular surgeons were less likely to use nonthermal modalities (OR, 0.95; 95% CI, 0.92-0.97), including new nonthermal technology in the first year of availability (OR, 0.93; 95% CI, 0.90-0.95). CONCLUSIONS: The use of venous procedures has increased rapidly during the past decade, particularly as endovenous ablations have been performed by a wider practitioner base, including APPs and noninterventionalists. Practice patterns differ by provider type, with APPs and cardiologists skewing more toward nonthermal modalities, including more rapid uptake of new nonthermal technology. Provider-specific biases for specific ablation modalities might reflect differences in training, skill set, the need for capital equipment, clinical privileges, or reimbursement. These data could help to inform training paradigms, the allocation of resources, and evaluation of appropriateness in a real-world setting.
引用
- Wiske C, Chervonski E, Rockman CB, et al. Venous ablation procedures by provider type, including advanced practice providers. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38518987. doi:10.1016/j.jvsv.2024.101872
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。